03Jun 2023
Expert Review on Contemporary Management of Common Benign Pleural Effusions

Expert Review on Contemporary Management of Common Benign Pleural Effusions

Heart failure (HF) and cirrhosis often lead to pleural effusions (PEs). Medical therapy involves diuretics, angiotensin receptor–neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors for HF. Nonselective beta-blockers should be avoided in hepatic hydrothorax (HH). Refractory PEs are managed with repeated thoracentesis or indwelling pleural catheter (IPC) insertion. Diuretic-resistant HH may require transjugular intrahepatic portosystemic shunts as a bridge to liver transplantation. Diagnosis of pleural tuberculosis (TB) remains challenging, but nucleic acid amplification tests can improve accuracy. Treatment follows guidelines for pulmonary TB, with special considerations for HIV-coinfected patients and drug resistance.

  • #critical care

Like

Save

Share